search
Back to results

Effectiveness of Instillation of Blue Water (Indigo Carmin®) for Colonoscopy (GRAND BLEU)

Primary Purpose

Adenoma Detection to Prevent Colorectal Cancer

Status
Unknown status
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Colonoscopy with blue Indigo Carmin®
Standard colonoscopy with insufflation of air
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Adenoma Detection to Prevent Colorectal Cancer focused on measuring Colonoscopy - Chromoendoscopy - Indigo Carmin® - Adenoma detection - Tepid water

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male or female patients 18 years of age or older
  • Scores 1 to 3 in ASA (American Society of Anesthesiologists) classification
  • Patient having an indication for of colonoscopy to detect colorectal neoplastic lesions, which meet at least one of the following conditions:

    • Positive fecal occult blood Test
    • 1st degree family history of colorectal cancer or adenoma before 60 years of age
    • Personal history of colorectal adenomas or colorectal cancer
    • Unexplained digestive symptoms after 50 years of age or those not responding to symptomatic treatment: modification of bowel movements, abdominal pains
    • Isolated or repeated rectal bleeding after 50 years of age or occult bleeding
    • Acromegaly
    • Infectious endocarditis with digestive bacteria
  • No coagulation anomalies or no taking of medicine affecting coagulation
  • Signing of informed consent form before the performance of any procedure related to the study

Exclusion Criteria:

  • Known inflammatory or infectious colorectal disease
  • Hereditary Non Polyposis Colorectal Cancer disease (Lynch syndrome) or family history of adenomatous polyposis
  • Histories of colorectal surgical resection
  • Known hypersensitivity to indigo Carmin® or to one of the preparation components
  • Pregnant or breastfeeding women, or those likely to become pregnant without effective contraception
  • patient not affiliated with a social security care system or who do not benefit from such a system
  • Patient over 18 years of age protected by the Law, under guardianship or curators
  • Concomitant participation in an interventional biomedical research trial

Sites / Locations

  • Hôpital Edouard HerriotRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Colonoscopy with blue indigo Carmin®

Standard colonoscopy

Arm Description

Patients undergoing from a colonoscopy with instillation of tepid water (30°C) tinged with indigo Carmin® (0,08/1000) during the endoscope insertion from the anus to the caecum, and with insufflation of air only during withdrawal from the caecum to the anus.

Standard colonoscopy with insufflation of air

Outcomes

Primary Outcome Measures

The rate of colonoscopy with at least one adenoma detected (or adenoma detection rate) confirmed by a histological reporting.

Secondary Outcome Measures

Measure 1: The characteristics of the lesions detected by the two types of colonoscopy (diameter, macroscopic appearance, histological nature)
We chose three classifications recognized by the medical field: The Paris endoscopic classification defines macroscopic appearance. The Kudo classification explains endoscopic appearance. The Vienna classification describes the histologic nature of the lesions.
Measure 2 Comparison of the time of the endoscope during the colonoscopy between the two methods
Measure 3 The comparison of the tolerance of the two colonoscopy procedures by assessing patient reported side effects.
Tolerance is measured using a Visual Analog Scale. The questionnaire includes four questions : Did you have any pains? How would you describe your bloating? How would you describe your sensations of abdominal discomfort? How would you describe your overall tolerance of the examination? In addition to this Visual Analog Scale, we administer a short multiple choice questionnaire: Would you be ready to redo the colonoscopy in the same conditions? (yes or no) For patients who have already had colonoscopies with insufflation of air in the past, which examination (tepid water or air) would you prefer during the next exam?

Full Information

First Posted
September 4, 2013
Last Updated
September 6, 2013
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT01937429
Brief Title
Effectiveness of Instillation of Blue Water (Indigo Carmin®) for Colonoscopy
Acronym
GRAND BLEU
Official Title
GRAND BLEU Study: Does the Colonoscopy With Instillation of Blue Water (Indigo Carmin® Dilute) Enable an Improved Rate of Adenoma Detection for Colonoscopy With Insufflation of Air?
Study Type
Interventional

2. Study Status

Record Verification Date
September 2013
Overall Recruitment Status
Unknown status
Study Start Date
January 2013 (undefined)
Primary Completion Date
April 2014 (Anticipated)
Study Completion Date
April 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The colonoscopy is the reference examination for the diagnosis of neoplastic lesions in the colon and rectum. Mass screening assessment studies have shown that colonoscopic detection and removal of adenomas in patients selected through fecal occult blood test reduces colorectal cancer incidence and mortality. However, the literature has reported interval cancer cases or adenomas, probably "missed" by the colonoscopy. In theory, using coloured warm water could improve colon preparation by mobilizing the residual faeces, decreasing the colic spasm and increasing the visualization of the pit pattern. Preliminary American studies, led by Leung et al, have shown a very clear increase in the adenoma detection rate. The investigators' study involves 1 000 patients, treated in the Rhône-Alpes / Auvergne region. The patients present an indication for colonoscopy following a positive fecal occult blood test or symptoms or personal and family histories of pre-cancerous colonic lesions. They will be randomized into two study groups:one of both groups of study: Group 1: patients undergoing a colonoscopy wtih instillation of tepid water tinged with blue (Indigo Carmin®) Group 2: patients undergoing a standard colonoscopy with insufflation of air. The main objective is to show that the colonoscopy with blue water (Indigo Carmin®) enable detection of more lesions than standard colonoscopy with insufflation of air. The two techniques will be also compared in terms of tolerance, of duration of colonoscopy and type of detected lesions. In case of improved detection of colorectal lesions, the blue water instillation technique of could dramatically change gastroenterologists' practice by becoming the reference method. The expected clinical benefits are potential revealing of more neoplastic lesions and improvement in abdominal discomfort after colonoscopy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adenoma Detection to Prevent Colorectal Cancer
Keywords
Colonoscopy - Chromoendoscopy - Indigo Carmin® - Adenoma detection - Tepid water

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Colonoscopy with blue indigo Carmin®
Arm Type
Experimental
Arm Description
Patients undergoing from a colonoscopy with instillation of tepid water (30°C) tinged with indigo Carmin® (0,08/1000) during the endoscope insertion from the anus to the caecum, and with insufflation of air only during withdrawal from the caecum to the anus.
Arm Title
Standard colonoscopy
Arm Type
Active Comparator
Arm Description
Standard colonoscopy with insufflation of air
Intervention Type
Device
Intervention Name(s)
Colonoscopy with blue Indigo Carmin®
Intervention Type
Device
Intervention Name(s)
Standard colonoscopy with insufflation of air
Primary Outcome Measure Information:
Title
The rate of colonoscopy with at least one adenoma detected (or adenoma detection rate) confirmed by a histological reporting.
Time Frame
Within the first 20 days after colonoscopy.
Secondary Outcome Measure Information:
Title
Measure 1: The characteristics of the lesions detected by the two types of colonoscopy (diameter, macroscopic appearance, histological nature)
Description
We chose three classifications recognized by the medical field: The Paris endoscopic classification defines macroscopic appearance. The Kudo classification explains endoscopic appearance. The Vienna classification describes the histologic nature of the lesions.
Time Frame
within the first 20 days after colonoscopy.
Title
Measure 2 Comparison of the time of the endoscope during the colonoscopy between the two methods
Time Frame
This data is available during the colonoscopy
Title
Measure 3 The comparison of the tolerance of the two colonoscopy procedures by assessing patient reported side effects.
Description
Tolerance is measured using a Visual Analog Scale. The questionnaire includes four questions : Did you have any pains? How would you describe your bloating? How would you describe your sensations of abdominal discomfort? How would you describe your overall tolerance of the examination? In addition to this Visual Analog Scale, we administer a short multiple choice questionnaire: Would you be ready to redo the colonoscopy in the same conditions? (yes or no) For patients who have already had colonoscopies with insufflation of air in the past, which examination (tepid water or air) would you prefer during the next exam?
Time Frame
At patient's awakening the day of colonoscopy or one day after

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or female patients 18 years of age or older Scores 1 to 3 in ASA (American Society of Anesthesiologists) classification Patient having an indication for of colonoscopy to detect colorectal neoplastic lesions, which meet at least one of the following conditions: Positive fecal occult blood Test 1st degree family history of colorectal cancer or adenoma before 60 years of age Personal history of colorectal adenomas or colorectal cancer Unexplained digestive symptoms after 50 years of age or those not responding to symptomatic treatment: modification of bowel movements, abdominal pains Isolated or repeated rectal bleeding after 50 years of age or occult bleeding Acromegaly Infectious endocarditis with digestive bacteria No coagulation anomalies or no taking of medicine affecting coagulation Signing of informed consent form before the performance of any procedure related to the study Exclusion Criteria: Known inflammatory or infectious colorectal disease Hereditary Non Polyposis Colorectal Cancer disease (Lynch syndrome) or family history of adenomatous polyposis Histories of colorectal surgical resection Known hypersensitivity to indigo Carmin® or to one of the preparation components Pregnant or breastfeeding women, or those likely to become pregnant without effective contraception patient not affiliated with a social security care system or who do not benefit from such a system Patient over 18 years of age protected by the Law, under guardianship or curators Concomitant participation in an interventional biomedical research trial
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mathieu PIOCHE, MD
Phone
04.72.11.01.45
Ext
+33
Email
mathieu.pioche@chu-lyon.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Laurent MAGAUD, CRA
Phone
04 72 11 51 64
Ext
+33
Email
laurent.magaud@chu-lyon.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thierry PONCHON, MD
Organizational Affiliation
Hôpital E. Herriot -Service d'hépato-gastroentérologie
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Edouard Herriot
City
Lyon
ZIP/Postal Code
69437
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mathieu PIOCHE, MD
Phone
04.72.11.01.45
Ext
+33
Email
mathieu.pioche@chu-lyon.fr
First Name & Middle Initial & Last Name & Degree
Laurent MAGAUD, CRA
Phone
04 72 11 51 64
Ext
+33
Email
laurent.magaud@chu-lyon.fr

12. IPD Sharing Statement

Citations:
PubMed Identifier
28399611
Citation
Lesne A, Rouquette O, Touzet S, Petit-Laurent F, Tourlonias G, Pasquion A, Rivory J, Aguero Garcete G, Scanzi J, Chalumeau S, Chambon-Augoyard C, Moussata D, Leger-Nguyen F, Degeorges S, Chauvenet M, Fontanges T, Baubet S, Brulet P, Billioud C, Thimonier E, Stroeymeyt-Martin K, Hamel B, Graillot E, Cruiziat C, Scalone O, O'Brien M, Pere-Verge D, Souquet JC, Phelip JM, Poincloux L, Poupon-Bourdy S, Denis A, Magaud L, Ponchon T, Pioche M. Adenoma detection with blue-water infusion colonoscopy: a randomized trial. Endoscopy. 2017 Aug;49(8):765-775. doi: 10.1055/s-0043-105073. Epub 2017 Apr 11.
Results Reference
derived

Learn more about this trial

Effectiveness of Instillation of Blue Water (Indigo Carmin®) for Colonoscopy

We'll reach out to this number within 24 hrs